Why the study?
Can argatroban anticoagulation be used successfully for carotid stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome?
Can argatroban anticoagulation be used successfully for carotid stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome?
Argatroban anticoagulation can be effectively used during carotid stent implantation in patients with heparin-induced thrombocytopenia and thrombosis syndrome.
Argatroban may enable carotid stenting in HITTS; single case leaves open need for prospective validation.
We report the first successful carotid stent implant in a patient with heparin-induced thrombocytopenia and thrombosis syndrome who presented with recurrent neurologic deficits secondary to severe carotid stenosis. Argatroban anticoagulation was used for the carotid stent deployment. We also present laboratory data that document effective procedural anticoagulation.
No takes yet. Share an insight, caveat, or question.
Rangel et al. (1998) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: